Reports Q1 revenue $169.18M, consensus $168.18M. The company said, “ATEC exists to revolutionize spine surgery, and our Q1 results show that our unique, end-to-end procedural ecosystem is continuing to drive rapid, durable growth. We are executing with discipline and delivering on our financial commitments, while continuing to invest in differentiated innovation. ATEC’s relentless, spine-only focus has made it the preferred destination. We are built to lead and our best is still yet to come.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC:
- Is ATEC a Buy, Before Earnings?
- Unusually active option classes on open April 15th
- Alphatec Holdings: Strategic Growth and Resilience Amid Economic Pressures with a Buy Rating
- Alphatec Holdings Implements Executive Salary Conversion Plan
- Alphatec Holdings: Strong Growth Potential and Undervalued Buy Opportunity